| 1/16/2022 |
LumiraDx (NASDAQ:LMDX) Upgraded to “Hold” by Zacks Investment Research |
dispatchtribunal.com |
Zacks Investment Research upgraded shares of LumiraDx (NASDAQ:LMDX) from a sell rating to a hold rating in a research report sent to investors on Wednesday, Zacks.com reports.According to Zacks, “LumiraDx Limited is a point of care diagnostics company. Its testing solutions are being deployed by governments and leading healthcare institutions across laboratories, urgent care, physician offices, pharmacies, schools and workplaces to screen, diagnose, and monitor wellness as well ... |
| 1/16/2022 |
LumiraDx (NASDAQ:LMDX) Upgraded to Hold by Zacks Investment Research |
etfdailynews.com |
Zacks Investment Research upgraded shares of LumiraDx (NASDAQ:LMDX) from a sell rating to a hold rating in a research note released on Wednesday morning, Zacks.com reports.According to Zacks, “LumiraDx Limited is a point of care diagnostics company. Its testing solutions are being deployed by governments and leading healthcare institutions across laboratories, urgent care, physician offices, pharmacies, schools and workplaces to screen, diagnose, and monitor wellness as well as ... |
| 1/16/2022 |
LumiraDx (NASDAQ:LMDX) Rating Increased to Hold at Zacks Investment Research |
baseballnewssource.com |
Zacks Investment Research upgraded shares of LumiraDx (NASDAQ:LMDX) from a sell rating to a hold rating in a research report sent to investors on Wednesday, Zacks.com reports.According to Zacks, “LumiraDx Limited is a point of care diagnostics company. Its testing solutions are being deployed by governments and leading healthcare institutions across laboratories, urgent care, physician offices, pharmacies, schools and workplaces to screen, diagnose, and monitor wellness as well ... |
| 1/11/2022 |
LumiraDx CRP Test Achieves CE Marking |
PR Newswire |
LONDON , Jan. 11, 2022 /PRNewswire/ -- LumiraDx (Nasdaq: LMDX ), a next-generation point of care diagnostics company, today announced its C-reactive protein (CRP) Test has achieved CE Marking. The LumiraDx CRP Test is a small, portable, fully automated, microfluidic immunoassay test used for the quantitative determination of C-reactive protein with results within four minutes. The measurement of CRP provides important information for the detection and evaluation of infection, and ... |
| 1/11/2022 |
LumiraDx has Commenced Shipments in Europe for its COVID-19 & Flu A/B Microfluidic Antigen Test |
PR Newswire |
LONDON , Jan. 11, 2022 /PRNewswire/ -- LumiraDx (Nasdaq: LMDX ), a next-generation point of care diagnostics company, today announced preliminary results for the fourth quarter of 2021 as well as expected full-year revenue.The company anticipates 2021 full-year revenues of $422 million compared to 2020 revenues of $139 million and 2021 fourth quarter revenues of $119 million compared to 2020 fourth quarter revenues of $101 million . This expected full ... |
| 1/11/2022 |
LumiraDx CRP Test Achieves CE Marking | 2022-01-11 | Press Releases | Stockhouse |
stockhouse.com |
LMDX 29 minutes ago LONDON , Jan. 11, 2022 /PRNewswire/ -- LumiraDx (Nasdaq: LMDX), a next-generation point of care diagnostics company, today announced its C-reactive protein (CRP) Test has achieved CE Marking. The LumiraDx CRP Test is a small, portable, fully automated, microfluidic immunoassay test used for the quantitative determination of C-reactive protein with results within four minutes. The measurement of CRP provides important information for the detection and ... |
| 1/11/2022 |
Achieves Marking |
PR Newswire |
LONDON , Jan. 11, LumiraDx (Nasdaq: LMDX ), a next-generation point of care diagnostics company, today announced its C-reactive protein (CRP) Test has achieved CE Marking. The LumiraDx CRP Test is a small, portable, fully automated, microfluidic immunoassay test used for the quantitative determination of C-reactive protein with results within four minutes. The measurement of CRP provides important information for the detection and evaluation of infection, and inflammation. In ... |
| 1/7/2022 |
Point of Care Diagnostics Market Size to Hit USD 93.21 Bn |
Globe Newswire |
Ottawa, Jan. 07, 2022 (GLOBE NEWSWIRE) -- According to Precedence Research, the global point of care diagnostics market size was valued at USD 36 billion in 2021. The COVID-19 pandemic’s worldwide impact has been unforeseen and devastating, with point of care diagnostics experiencing a positive demand across all around the world. Because of the global frequency of chronic and acute diseases, there is a growing demand for high quality ... |
| 12/31/2021 |
Global Point of Care Diagnostics Market Report 2021, Featuring Abbott, Siemens Healthcare, F. Hoffmann-La Roche, Medtronic, Chembio Diagnostics and Philips Healthcare |
PR Newswire |
... the most active segments within the diagnostic industry.POC testing is growing in both home use and POC testing near-patient applications. Both segments are included in this market study.The global market for point of care diagnostics was valued at $24.8 billion in 2021. The market is expected to grow at a compound annual growth rate (CAGR) of 11.9% to reach $43.5 billion by 2026. The major factor contributing ... |
| 12/31/2021 |
US Regulators Clear New Rapid COVID-19 Test Amid Widespread Shortages |
causeaction.com |
... high-quality test, already used and trusted by families, medical professionals, businesses and governments in many parts of the world, to the United States under FDA Emergency Use Authorization,” Christoph Pedain, head of point of care diagnostics for Siemens, said in a statement.Lines at testing sites across the nation have swelled in recent weeks as the Omicron variant of the CCP (Chinese Communist Party) virus became dominant. The ... |
| 12/30/2021 |
Point of Care Diagnostics Market and the Impact of COVID-19: Prioritizing of OTC and At-Home Testing Solutions |
Globe Newswire |
... the most active segments within the diagnostic industry.POC testing is growing in both home use and POC testing near-patient applications. Both segments are included in this market study.The global market for point of care diagnostics was valued at $24.8 billion in 2021. The market is expected to grow at a compound annual growth rate (CAGR) of 11.9% to reach $43.5 billion by 2026. The major factor contributing ... |
| 12/30/2021 |
Point of Care Diagnostics Market and the Impact of |
Globe Newswire |
... the most active segments within the diagnostic industry.POC testing is growing in both home use and POC testing near-patient applications. Both segments are included in this market study.The global market for point of care diagnostics was valued at $24.8 billion in 2021. The market is expected to grow at a compound annual growth rate (CAGR) of 11.9% to reach $43.5 billion by 2026. The major factor contributing ... |
| 12/30/2021 |
Point of Care Diagnostics: Technologies and Global Markets |
Wordpress.com |
Bharat Book Bureau Provides the Trending Market Research Report on “ Point of Care Diagnostics : Technologies and Global Markets “ under Life Sciences category. The Global Point of Care Diagnostics Market is projected to exhibit highest growth rate over report offers a collection of superior market research, market analysis, and competitive intelligence and industry reports.Report Scope:This research report presents an in-depth analysis of the global Point of ... |
| 12/30/2021 |
Siemens Healthineers gets EUA from FDA for Covid-19 antigen self-test |
medicaldevice-network.com |
... from individuals between the age of two and 13 years.Siemens Healthineers stated that it has secured the production capacity for the test kit in the tens of millions in a month.Siemens Healthineers Point of Care Diagnostics head Christoph Pedain said: “Undetected Covid-19 exposure is a major driver of community spread. With the Test, consumers will have access to a fast, reliable, and convenient test to provide additional ... |
| 12/30/2021 |
FDA approves new at-home rapid COVID-19 test | Washington Examiner |
Washington Examiner |
... driver of community spread. With the CLINITEST Rapid COVID-19 Antigen Self-Test, consumers will have access to a fast, reliable, and convenient test to provide additional safety,” said Christoph Pedain, head of point of care diagnostics , in a statement . “Siemens Healthineers is proud to bring this high-quality test, already used and trusted by families, medical professionals, businesses and governments in many parts of the world, to the ... |
| 12/29/2021 |
Global Point of Care Diagnostics Market Forecast to Reach $43.5 Billion by 2026 - ResearchAndMarkets.com | Business | The Daily News |
galvnews.com |
... the most active segments within the diagnostic industry.POC testing is growing in both home use and POC testing near-patient applications. Both segments are included in this market study.The global market for point of care diagnostics was valued at $24.8 billion in 2021. The market is expected to grow at a compound annual growth rate (CAGR) of 11.9% to reach $43.5 billion by 2026. The major factor contributing ... |
| 12/29/2021 |
Global Point of Care Diagnostics Market Forecast to Reach $43.5 Billion by 2026 - ResearchAndMarkets.com |
Business Wire |
... the most active segments within the diagnostic industry.POC testing is growing in both home use and POC testing near-patient applications. Both segments are included in this market study.The global market for point of care diagnostics was valued at $24.8 billion in 2021. The market is expected to grow at a compound annual growth rate (CAGR) of 11.9% to reach $43.5 billion by 2026. The major factor contributing ... |
| 12/28/2021 |
Lord's Mark Industries Enters Medtech with Distribution Partnerships, Launches Health Kiosks to Boost Public Healthcare Infrastructure |
easternherald.com |
... developed contactless Remote Patient Monitoring device in public hospitals. In addition, LordsMed has launched its health kiosk with the brand name of Lords Sehat. The health kiosks are walk-in clinics equipped with integrated point of care diagnostics .The remote patient monitoring device allows healthcare providers to remotely monitor patients’ vital signs, receive updates and deterioration alerts within hospital, home and other care settings outside the hospital as well ... |
| 12/28/2021 |
Lord's Mark Industries enters Medtech with Distribution Partnerships, launches Health Kiosks to boost public healthcare infrastructure |
newkerala.com |
... developed contactless Remote Patient Monitoring device in public hospitals.In addition, LordsMed has launched its health kiosk with the brand name of Lords Sehat. The health kiosks are walk-in clinics equipped with integrated point of care diagnostics .The remote patient monitoring device allows healthcare providers to remotely monitor patients' vital signs, receive updates and deterioration alerts within the hospital, home and other care settings outside the hospital as well ... |
| 12/20/2021 |
Point of Care Diagnostics: Technologies and Global Markets |
Globe Newswire |
... the report "Point of Care Diagnostics: Technologies and Global Markets" - https://www.reportlinker.com/p05800362/?utm_source=GNWThe report also covers market projections through 2026, as well as key market players.This report discusses the point of care diagnostics industry and its various resources.It covers the overall point of care diagnostics market including hardware (devices, equipment, consumables (reagents and kits)), software and analytics.The report further analyzes the market based on ... |